Skip to content
BABYLAT logo — Solution to save the most fragile lives

BABYLAT

Solution to save the most fragile lives

Founded 2021 Switzerland Bern, Switzerland 5 employees Non Equity Assistance Total: $30.00K Medical Devices

General Information

Company Name BABYLAT
Founded Year 2021
Location Switzerland Bern, Switzerland
Employees 5
Industries Medical Devices
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with BABYLAT. To contact BABYLAT, visit babylat.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BABYLAT compare?

A PDF of BABYLAT and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BABYLAT soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BABYLAT

BABYLAT is a Swiss-based startup that was founded in 2021, with a focus on the Medical Devices industry. The company's slogan, "Solution to save the most fragile lives," reflects its commitment to addressing critical healthcare needs. BABYLAT recently received a Non Equity Assistance investment on 17 May 2021 from MassChallenge Switzerland. The startup's innovative approach to medical devices and its potential to make a significant impact in saving lives make it an intriguing prospect for venture capital firms seeking to support groundbreaking advancements in healthcare technology.

Business keywords: medical, saving lives, fragile populations, life-saving technologies, innovation, health technology, critical care, emergency response, public health, vulnerable populations

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MassChallenge Switzerland
17 May 2021
Grant Fr.30.00K 1
Ypsomed Innovation Fund
07 Jan 2021

BABYLAT Alternatives & Competitors

View All Alternatives
BABYLAT vs

Our mission is to save lives by lowering the training barrier for internal hemorrhage diagnosis.

Grant
3 employees
Health Care, Medical Devices
BABYLAT vs

Protecting the Vulnerable®

Post-IPO Equity
313 employees
Biotechnology, Manufacturing
BABYLAT vs
StationMD
StationMD United States

The Exceptional Telehealth Solution for Vulnerable Populations

Venture round
75 employees
Health Care, Medical Devices

FAQ About BABYLAT

Solution to save the most fragile lives
BABYLAT was founded in 2021.
BABYLAT is headquartered in Bern, Switzerland.
BABYLAT operates in Medical Devices. Its work centres on medical, saving lives, fragile populations and life-saving technologies.
BABYLAT has approximately 5 employees.
BABYLAT has completed 2 funding rounds, raising a total of $30.00K. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to BABYLAT include DioTeX Diagnostics, LLC, Mesa Laboratories, Inc., StationMD, Archeon Medical, MasksOn.org. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BABYLAT and DioTeX Diagnostics, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BABYLAT, https://bouncewatch.com/company/babylat, updated 1 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout